Biotage AB (publ) (LON:0GRP)
London
· Delayed Price · Currency is GBP · Price in SEK 140.00
+0.29 (0.21%)
At close: Apr 24, 2025
Biotage AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,961 | 2,056 | 1,862 | 1,566 | 1,232 | 1,092 | Upgrade
|
| Revenue Growth (YoY) | -1.01% | 10.42% | 18.90% | 27.11% | 12.82% | -0.85% | Upgrade
|
| Cost of Revenue | 733 | 767 | 713 | 618 | 477 | 426 | Upgrade
|
| Gross Profit | 1,228 | 1,289 | 1,149 | 948 | 755 | 666 | Upgrade
|
| Selling, General & Admin | 780 | 797 | 669 | 529 | 396 | 375 | Upgrade
|
| Research & Development | 180 | 180 | 159 | 109 | 91 | 72 | Upgrade
|
| Other Operating Expenses | -67 | -67 | 2 | 17 | 1 | 31 | Upgrade
|
| Operating Expenses | 893 | 910 | 830 | 655 | 488 | 478 | Upgrade
|
| Operating Income | 335 | 379 | 319 | 293 | 267 | 188 | Upgrade
|
| Interest Expense | - | -17 | -13 | -5 | -3 | -3 | Upgrade
|
| Interest & Investment Income | 36 | 12 | 10 | 2 | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -1 | Upgrade
|
| Currency Exchange Gain (Loss) | -33 | -20 | 6 | 26 | 7 | 14 | Upgrade
|
| Other Non Operating Income (Expenses) | -26 | -26 | -28 | 5 | -1 | - | Upgrade
|
| EBT Excluding Unusual Items | 312 | 328 | 294 | 321 | 270 | 198 | Upgrade
|
| Merger & Restructuring Charges | -22 | - | - | - | -8 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -1 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -1 | -3 | - | Upgrade
|
| Other Unusual Items | - | - | 9 | 28 | 10 | 25 | Upgrade
|
| Pretax Income | 290 | 328 | 303 | 348 | 269 | 222 | Upgrade
|
| Income Tax Expense | 35 | 44 | 57 | 80 | 64 | 47 | Upgrade
|
| Net Income | 255 | 284 | 246 | 268 | 205 | 175 | Upgrade
|
| Net Income to Common | 255 | 284 | 246 | 268 | 205 | 175 | Upgrade
|
| Net Income Growth | 8.05% | 15.45% | -8.21% | 30.73% | 17.14% | -6.33% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 80 | 74 | 66 | 65 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 80 | 80 | 74 | 66 | 65 | 65 | Upgrade
|
| Shares Change (YoY) | 3.44% | 8.25% | 11.80% | 1.10% | 0.39% | 0.04% | Upgrade
|
| EPS (Basic) | 3.19 | 3.55 | 3.33 | 4.06 | 3.14 | 2.68 | Upgrade
|
| EPS (Diluted) | 3.18 | 3.55 | 3.33 | 4.04 | 3.13 | 2.68 | Upgrade
|
| EPS Growth | 4.21% | 6.57% | -17.57% | 29.07% | 16.62% | -6.35% | Upgrade
|
| Free Cash Flow | 264 | 324 | 258 | 306 | 330 | 261 | Upgrade
|
| Free Cash Flow Per Share | 3.29 | 4.04 | 3.49 | 4.62 | 5.04 | 4.00 | Upgrade
|
| Dividend Per Share | 1.650 | 1.650 | 1.600 | 1.600 | 1.550 | 1.500 | Upgrade
|
| Dividend Growth | 3.13% | 3.13% | - | 3.23% | 3.33% | - | Upgrade
|
| Gross Margin | 62.62% | 62.70% | 61.71% | 60.54% | 61.28% | 60.99% | Upgrade
|
| Operating Margin | 17.08% | 18.43% | 17.13% | 18.71% | 21.67% | 17.22% | Upgrade
|
| Profit Margin | 13.00% | 13.81% | 13.21% | 17.11% | 16.64% | 16.03% | Upgrade
|
| Free Cash Flow Margin | 13.46% | 15.76% | 13.86% | 19.54% | 26.79% | 23.90% | Upgrade
|
| EBITDA | 453 | 503 | 413 | 343 | 296 | 217 | Upgrade
|
| EBITDA Margin | 23.10% | 24.46% | 22.18% | 21.90% | 24.03% | 19.87% | Upgrade
|
| D&A For EBITDA | 118 | 124 | 94 | 50 | 29 | 29 | Upgrade
|
| EBIT | 335 | 379 | 319 | 293 | 267 | 188 | Upgrade
|
| EBIT Margin | 17.08% | 18.43% | 17.13% | 18.71% | 21.67% | 17.22% | Upgrade
|
| Effective Tax Rate | 12.07% | 13.41% | 18.81% | 22.99% | 23.79% | 21.17% | Upgrade
|
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.